Spyre Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Spyre Therapeutics, Inc. annual/quarterly Payments to Acquire Property, Plant, and Equipment history and growth rate from 2014 to 2023.
  • Spyre Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2022 was $37K, a 91.8% decline year-over-year.
  • Spyre Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $0.000, a 100% decline from 2022.
  • Spyre Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $38K, a 93.4% decline from 2021.
  • Spyre Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $573K, a 86.6% decline from 2020.
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 -$38K -100% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $38K -$535K -93.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $573K -$3.71M -86.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $4.28M +$2.79M +187% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $1.49M +$1.07M +254% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-08
2018 $422K -$197K -31.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 $619K +$407K +192% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $212K +$4K +1.92% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $208K +$27K +14.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-13
2014 $181K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.